 | • レポートコード：MRC2012A4676 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ヒト成長ホルモン治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒト成長ホルモン治療薬の種類別市場規模（ノルディトロピン、ジェノトロピン、フマトロープ、サイゼン、オムニトロープ-ソマトロピンバイオシミラー、ソマトロピンバイオパートナー）、用途別市場規模（プラダーウィリー症候群、ターナー症候群、低身長ホメオボックス遺伝子、低出生体重児、慢性腎不全、短腸症候群）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Eli Lilly and Company (US)、Sandoz International GmbH (Germany)、GeneScience Pharmaceuticals Co., Ltd. (China)、Ferring Holding SA (Switzerland)、Pfizer, Inc. (US)、Genentech, Inc. (US)、Novo Nordisk A/S (Denmark)、Merck KgaA (Germany)、 ・地域別グローバル市場分析 2015年-2020年 ・ヒト成長ホルモン治療薬の北米市場（アメリカ、カナダ、メキシコ） ・ヒト成長ホルモン治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ヒト成長ホルモン治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ヒト成長ホルモン治療薬の南米市場（ブラジル、アルゼンチン） ・ヒト成長ホルモン治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ノルディトロピン、ジェノトロピン、フマトロープ、サイゼン、オムニトロープ-ソマトロピンバイオシミラー、ソマトロピンバイオパートナー ・用途別分析：プラダーウィリー症候群、ターナー症候群、低身長ホメオボックス遺伝子、低出生体重児、慢性腎不全、短腸症候群 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Human Growth Hormone Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 292.2 million by 2025, from USD 250 million in 2019.
The Human Growth Hormone Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Human Growth Hormone Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Human Growth Hormone Drugs market has been segmented into
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope – the Somatropin Biosimilar
Somatropin Biopartners
By Application, Human Growth Hormone Drugs has been segmented into:
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Growth Hormone Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Growth Hormone Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Growth Hormone Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Human Growth Hormone Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Human Growth Hormone Drugs Market Share Analysis
Human Growth Hormone Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Growth Hormone Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Growth Hormone Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Human Growth Hormone Drugs are:
Eli Lilly and Company (US)
Sandoz International GmbH (Germany)
GeneScience Pharmaceuticals Co., Ltd. (China)
Ferring Holding SA (Switzerland)
Pfizer, Inc. (US)
Genentech, Inc. (US)
Novo Nordisk A/S (Denmark)
Merck KgaA (Germany)
Among other players domestic and global, Human Growth Hormone Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Growth Hormone Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Growth Hormone Drugs, with price, sales, revenue and global market share of Human Growth Hormone Drugs in 2018 and 2019.
Chapter 3, the Human Growth Hormone Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Growth Hormone Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Human Growth Hormone Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Human Growth Hormone Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Human Growth Hormone Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Growth Hormone Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Norditropin
1.2.3 Genotropin
1.2.4 Humatrope
1.2.5 Saizen
1.2.6 Omnitrope – the Somatropin Biosimilar
1.2.7 Somatropin Biopartners
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Growth Hormone Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Prader-Willi Syndrome
1.3.3 Turner Syndrome
1.3.4 Short Stature Homeobox Gene
1.3.5 Small for Gestational Age
1.3.6 Chronic Renal Insufficiency
1.3.7 Short Bowel Syndrome
1.4 Overview of Global Human Growth Hormone Drugs Market
1.4.1 Global Human Growth Hormone Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly and Company (US)
2.1.1 Eli Lilly and Company (US) Details
2.1.2 Eli Lilly and Company (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly and Company (US) SWOT Analysis
2.1.4 Eli Lilly and Company (US) Product and Services
2.1.5 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sandoz International GmbH (Germany)
2.2.1 Sandoz International GmbH (Germany) Details
2.2.2 Sandoz International GmbH (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sandoz International GmbH (Germany) SWOT Analysis
2.2.4 Sandoz International GmbH (Germany) Product and Services
2.2.5 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GeneScience Pharmaceuticals Co., Ltd. (China)
2.3.1 GeneScience Pharmaceuticals Co., Ltd. (China) Details
2.3.2 GeneScience Pharmaceuticals Co., Ltd. (China) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GeneScience Pharmaceuticals Co., Ltd. (China) SWOT Analysis
2.3.4 GeneScience Pharmaceuticals Co., Ltd. (China) Product and Services
2.3.5 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ferring Holding SA (Switzerland)
2.4.1 Ferring Holding SA (Switzerland) Details
2.4.2 Ferring Holding SA (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ferring Holding SA (Switzerland) SWOT Analysis
2.4.4 Ferring Holding SA (Switzerland) Product and Services
2.4.5 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer, Inc. (US)
2.5.1 Pfizer, Inc. (US) Details
2.5.2 Pfizer, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer, Inc. (US) SWOT Analysis
2.5.4 Pfizer, Inc. (US) Product and Services
2.5.5 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Genentech, Inc. (US)
2.6.1 Genentech, Inc. (US) Details
2.6.2 Genentech, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Genentech, Inc. (US) SWOT Analysis
2.6.4 Genentech, Inc. (US) Product and Services
2.6.5 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novo Nordisk A/S (Denmark)
2.7.1 Novo Nordisk A/S (Denmark) Details
2.7.2 Novo Nordisk A/S (Denmark) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Novo Nordisk A/S (Denmark) SWOT Analysis
2.7.4 Novo Nordisk A/S (Denmark) Product and Services
2.7.5 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck KgaA (Germany)
2.8.1 Merck KgaA (Germany) Details
2.8.2 Merck KgaA (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck KgaA (Germany) SWOT Analysis
2.8.4 Merck KgaA (Germany) Product and Services
2.8.5 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human Growth Hormone Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human Growth Hormone Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Growth Hormone Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Human Growth Hormone Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human Growth Hormone Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Human Growth Hormone Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Growth Hormone Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
4.5 South America Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human Growth Hormone Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Human Growth Hormone Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Human Growth Hormone Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human Growth Hormone Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Human Growth Hormone Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human Growth Hormone Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
6.3 UK Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
6.4 France Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human Growth Hormone Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human Growth Hormone Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human Growth Hormone Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
7.5 India Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human Growth Hormone Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Human Growth Hormone Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Human Growth Hormone Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human Growth Hormone Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human Growth Hormone Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human Growth Hormone Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human Growth Hormone Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Human Growth Hormone Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Human Growth Hormone Drugs Price by Type (2015-2020)
11 Global Human Growth Hormone Drugs Market Segment by Application
11.1 Global Human Growth Hormone Drugs Sales Market Share by Application (2015-2020)
11.2 Global Human Growth Hormone Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Human Growth Hormone Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human Growth Hormone Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Human Growth Hormone Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Human Growth Hormone Drugs Market Forecast (2021-2025)
12.2.2 Europe Human Growth Hormone Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human Growth Hormone Drugs Market Forecast (2021-2025)
12.2.4 South America Human Growth Hormone Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human Growth Hormone Drugs Market Forecast (2021-2025)
12.3 Human Growth Hormone Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Human Growth Hormone Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Human Growth Hormone Drugs Market Share Forecast by Type (2021-2025)
12.4 Human Growth Hormone Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Human Growth Hormone Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Human Growth Hormone Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Human Growth Hormone Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Growth Hormone Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Growth Hormone Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Eli Lilly and Company (US) Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly and Company (US) Human Growth Hormone Drugs Major Business
Table 9. Eli Lilly and Company (US) Human Growth Hormone Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Eli Lilly and Company (US) SWOT Analysis
Table 11. Eli Lilly and Company (US) Human Growth Hormone Drugs Product and Services
Table 12. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sandoz International GmbH (Germany) Basic Information, Manufacturing Base and Competitors
Table 14. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Major Business
Table 15. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Sandoz International GmbH (Germany) SWOT Analysis
Table 17. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product and Services
Table 18. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GeneScience Pharmaceuticals Co., Ltd. (China) Basic Information, Manufacturing Base and Competitors
Table 20. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Major Business
Table 21. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Total Revenue (USD Million) (2017-2018)
Table 22. GeneScience Pharmaceuticals Co., Ltd. (China) SWOT Analysis
Table 23. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product and Services
Table 24. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Ferring Holding SA (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 26. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Major Business
Table 27. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Ferring Holding SA (Switzerland) SWOT Analysis
Table 29. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product and Services
Table 30. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Pfizer, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer, Inc. (US) Human Growth Hormone Drugs Major Business
Table 33. Pfizer, Inc. (US) Human Growth Hormone Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Pfizer, Inc. (US) SWOT Analysis
Table 35. Pfizer, Inc. (US) Human Growth Hormone Drugs Product and Services
Table 36. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Genentech, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 38. Genentech, Inc. (US) Human Growth Hormone Drugs Major Business
Table 39. Genentech, Inc. (US) Human Growth Hormone Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Genentech, Inc. (US) SWOT Analysis
Table 41. Genentech, Inc. (US) Human Growth Hormone Drugs Product and Services
Table 42. Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Novo Nordisk A/S (Denmark) Basic Information, Manufacturing Base and Competitors
Table 44. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Major Business
Table 45. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Novo Nordisk A/S (Denmark) SWOT Analysis
Table 47. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product and Services
Table 48. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck KgaA (Germany) Basic Information, Manufacturing Base and Competitors
Table 50. Merck KgaA (Germany) Human Growth Hormone Drugs Major Business
Table 51. Merck KgaA (Germany) Human Growth Hormone Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Merck KgaA (Germany) SWOT Analysis
Table 53. Merck KgaA (Germany) Human Growth Hormone Drugs Product and Services
Table 54. Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Human Growth Hormone Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 56. Global Human Growth Hormone Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Human Growth Hormone Drugs Sales by Regions (2015-2020) (K Pcs)
Table 58. Global Human Growth Hormone Drugs Sales Market Share by Regions (2015-2020)
Table 59. Global Human Growth Hormone Drugs Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Human Growth Hormone Drugs Sales by Countries (2015-2020) (K Pcs)
Table 61. North America Human Growth Hormone Drugs Sales Market Share by Countries (2015-2020)
Table 62. North America Human Growth Hormone Drugs Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Human Growth Hormone Drugs Revenue Market Share by Countries (2015-2020)
Table 64. Europe Human Growth Hormone Drugs Sales by Countries (2015-2020) (K Pcs)
Table 65. Europe Human Growth Hormone Drugs Sales Market Share by Countries (2015-2020)
Table 66. Europe Human Growth Hormone Drugs Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Human Growth Hormone Drugs Sales by Regions (2015-2020) (K Pcs)
Table 68. Asia-Pacific Human Growth Hormone Drugs Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Human Growth Hormone Drugs Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Human Growth Hormone Drugs Sales by Countries (2015-2020) (K Pcs)
Table 71. South America Human Growth Hormone Drugs Sales Market Share by Countries (2015-2020)
Table 72. South America Human Growth Hormone Drugs Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Human Growth Hormone Drugs Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Human Growth Hormone Drugs Sales by Countries (2015-2020) (K Pcs)
Table 75. Middle East & Africa Human Growth Hormone Drugs Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Human Growth Hormone Drugs Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Human Growth Hormone Drugs Revenue Market Share by Countries (2015-2020)
Table 78. Global Human Growth Hormone Drugs Sales by Type (2015-2020) (K Pcs)
Table 79. Global Human Growth Hormone Drugs Sales Share by Type (2015-2020)
Table 80. Global Human Growth Hormone Drugs Revenue by Type (2015-2020) (USD Million)
Table 81. Global Human Growth Hormone Drugs Revenue Share by Type (2015-2020)
Table 82. Global Human Growth Hormone Drugs Sales by Application (2015-2020) (K Pcs)
Table 83. Global Human Growth Hormone Drugs Sales Share by Application (2015-2020)
Table 84. Global Human Growth Hormone Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 85. Global Human Growth Hormone Drugs Market Share Forecast by Regions (2021-2025)
Table 86. Global Human Growth Hormone Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 87. Global Human Growth Hormone Drugs Market Share Forecast by Type (2021-2025)
Table 88. Global Human Growth Hormone Drugs Sales Forecast by Application (2021-2025)
Table 89. Global Human Growth Hormone Drugs Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Human Growth Hormone Drugs Picture
Figure 2. Global Sales Market Share of Human Growth Hormone Drugs by Type in 2019
Figure 3. Norditropin Picture
Figure 4. Genotropin Picture
Figure 5. Humatrope Picture
Figure 6. Saizen Picture
Figure 7. Omnitrope - the Somatropin Biosimilar Picture
Figure 8. Somatropin Biopartners Picture
Figure 9. Human Growth Hormone Drugs Sales Market Share by Application in 2018
Figure 10. Prader-Willi Syndrome Picture
Figure 11. Turner Syndrome Picture
Figure 12. Short Stature Homeobox Gene Picture
Figure 13. Small for Gestational Age Picture
Figure 14. Chronic Renal Insufficiency Picture
Figure 15. Short Bowel Syndrome Picture
Figure 16. Global Human Growth Hormone Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Human Growth Hormone Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Human Growth Hormone Drugs Sales Market Share by Manufacturer in 2019
Figure 37. Global Human Growth Hormone Drugs Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Human Growth Hormone Drugs Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Human Growth Hormone Drugs Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 42. Global Human Growth Hormone Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Human Growth Hormone Drugs Revenue Market Share by Regions (2015-2020)
Figure 44. Global Human Growth Hormone Drugs Revenue Market Share by Regions in 2018
Figure 45. North America Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
Figure 46. Europe Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
Figure 48. South America Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Human Growth Hormone Drugs Sales and Growth Rate (2015-2020)
Figure 50. North America Human Growth Hormone Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Human Growth Hormone Drugs Sales Market Share by Countries (2015-2020)
Figure 52. North America Human Growth Hormone Drugs Sales Market Share by Countries in 2018
Figure 53. North America Human Growth Hormone Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Human Growth Hormone Drugs Revenue Market Share by Countries in 2018
Figure 55. United States Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Canada Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Mexico Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Europe Human Growth Hormone Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Human Growth Hormone Drugs Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Human Growth Hormone Drugs Revenue Market Share by Countries in 2019
Figure 61. Germany Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. UK Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. France Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Russia Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Italy Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Asia-Pacific Human Growth Hormone Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Human Growth Hormone Drugs Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Human Growth Hormone Drugs Revenue Market Share by Regions 2019
Figure 69. China Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Korea Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. India Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Southeast Asia Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. South America Human Growth Hormone Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Human Growth Hormone Drugs Sales Market Share by Countries in 2019
Figure 76. South America Human Growth Hormone Drugs Revenue Market Share by Countries in 2019
Figure 77. Brazil Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Argentina Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Middle East and Africa Human Growth Hormone Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Human Growth Hormone Drugs Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Human Growth Hormone Drugs Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Human Growth Hormone Drugs Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Egypt Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Turkey Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. South Africa Human Growth Hormone Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 87. Global Human Growth Hormone Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 88. Global Human Growth Hormone Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Human Growth Hormone Drugs Market Forecast (2021-2025) (K Pcs)
Figure 90. Europe Sales Human Growth Hormone Drugs Market Forecast (2021-2025) (K Pcs)
Figure 91. Asia-Pacific Sales Human Growth Hormone Drugs Market Forecast (2021-2025) (K Pcs)
Figure 92. South America Sales Human Growth Hormone Drugs Market Forecast (2021-2025) (K Pcs)
Figure 93. Middle East & Africa Sales Human Growth Hormone Drugs Market Forecast (2021-2025) (K Pcs)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
ヒト成長ホルモン治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Growth Hormone Drugs Market The global Human Growth Hormone Drugs market size is projected to reach US$ 253.9 million by 2026, from US$ 243 million in 2020, at a CAGR of 4.2%% during 2021-2026. Global Human Growth Hormone Drugs Scope and Market Size Human G…- ヒト成長ホルモン（hGH）の世界市場（～2026年） Growth hormone(GH),also known as somatotropin(or as human growth hormone [hGH or HGH] in its human form),is a peptide hormone that stimulates growth, cell reproduction,and cell regeneration in humans and other animals. The growing application of growth hormones in treating many diseases and conditio…
- ヒトマイクロバイオームベース薬剤・診断の世界市場（～2026年） The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness. Rising cases of ch…
- ヒト呼吸器合胞体ウイルス薬の世界市場（～2026年） Human respiratory syncytial virus (HRSV) is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood. A prophylactic medication, palivizumab, can be employed to prevent HRSV in preterm (unde…
- 成長ホルモン欠乏症治療の世界市場（～2026年） Growth hormone deficiency (GHD) is a medical condition characterized by insufficient production of somatropin, a growth hormone, from the anterior pituitary gland which is responsible for the growth and cell reproduction. The primary factor contributing to the growth of global growth hormone deficie…